20 May 2020 --- More than a year has passed since cannabidiol (CBD) was classified as a novel food in January 2019, yet the regulatory situation regarding its safety and applications is still far from clear. However, this has not slowed down NPD in foods and beverages, as well as personal care and pharma applications. Increased demand has also led to the rise of alternatives, such as palmitoylethanolamide (PEA). NutritionInsight examines what is trending in the CBD space, how regulations are progressing and to what extent the sector is affected by the COVID-19 pandemic.
